RANBP9 and Alzheimer disease: RanBPM has been shown to play a pathogenic role in AD as it acts as a scaffold bringing together amyloid precursor protein (APP), low-density lipoprotein receptor-related protein (LRP) and β-site APP-cleaving enzyme 1 (BACE1) [54].